share_log

Field Trip Health & Wellness Announces Posting on the OTC Market

Field Trip Health & Wellness Announces Posting on the OTC Market

實地考察健康與保健宣布在場外交易市場上發布
GlobeNewswire ·  2023/02/03 20:35

Trading on the OTCQB Effective February 2, 2023, under the Symbol "FTHWF"

OTCQB的交易將於2023年2月2日生效,交易代碼為“FTHWF”

TORONTO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or "Field Trip"), global leader in the delivery of psychedelic therapies, is pleased to announce that the Company has received approval from the Financial Regulatory Authority ("FINRA") for its shares to commence trading on the OTCQB Market ("the OTCQB") in the United States under the symbol "FTHWF" effective February 2, 2023. Field Trip will continue to trade on the TSX Venture Exchange under its existing symbol "FTHW".

多倫多,2023年2月3日(環球網)--提供迷幻療法的全球領先供應商--野遊健康健康有限公司(多倫多證券交易所股票代碼:FTHW)(以下簡稱“公司”或“野遊”)欣然宣佈,該公司已獲得美國金融監管局(FINRA)的批准,其股票將於2023年2月2日在美國場外交易市場(OTCQB)開始交易,交易代碼為“FTHWF”。FieldTrip將繼續在多倫多證券交易所創業板交易,現有代碼為“FTHW”。

Ronan Levy, Chairman and Chief Executive Officer of Field Trip Health & Wellness, stated, "Being posted on the OTCQB is a key milestone in our evolution as one of today's leading providers of psychedelic therapy. As we enhance our efforts to bring a more holistic treatment program to the forefront of the mental health industry that combines technology, medicine, well-being, and community, it is of key importance that our progress is shared with a broad investor base. By trading on the OTCQB, we can achieve increased visibility of Field Trip to U.S. investors and improve our overall liquidity as we grow our global shareholder base."

Field Trip Health&Wellness董事長兼首席執行官Ronan Levy表示:“被貼在OTCQB上是我們作為當今領先的迷幻療法提供商之一發展過程中的一個關鍵里程碑。隨着我們加大努力,將更全面的治療計劃帶到精神健康行業的前沿,將技術、醫學、福祉和社區結合在一起,與廣泛的投資者基礎分享我們的進展是至關重要的。通過在OTCQB上進行交易,我們可以提高美國投資者對field Trip的可見度,並在我們擴大全球股東基礎的同時改善我們的整體流動性。”

The Company also announced that as a result, in part, of the announcement by the US government of its intention to end the Public Health Emergency related to the COVID-19 Pandemic (the "PHE"), it is re-evaluating its Freedom by Field Trip program. The Freedom by Field Trip program relies on an exception to the Ryan Haight Act that permitted prescribing of controlled substances such as ketamine by telemedicine during the PHE. With the end of the PHE occurring in the first half of 2023, the Company is evaluating its strategy around the Freedom by Field Trip program and, as a result, has stopped enrolling new clients in the program.

該公司還宣佈,部分由於美國政府宣佈打算結束與新冠肺炎大流行相關的突發公共衞生事件(“PHE”),該公司正在重新評估其自由實地旅行計劃。自由實地旅行方案依賴於瑞安·海特法案的一個例外,該法案允許在公共衞生教育期間通過遠程醫療開出氯胺酮等受控物質的處方。隨着PHE將於2023年上半年結束,該公司正在評估其圍繞自由實地旅行計劃的戰略,因此已停止在該計劃中招收新客户。

About Field Trip Health & Wellness Ltd.

關於野外旅行健康與健康有限公司。

With a large global community of psychedelic-interested people, proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.

擁有一個龐大的全球迷幻人羣社區,專有的迷幻療法可以為人們的心理健康治療帶來革命性的結果,而且有一個品牌和分享的聲音正在接觸到數百萬人,菲爾德旅行是迷幻復興的重心。

Learn more at and

瞭解更多信息,請訪問和

Follow us on Twitter and Instagram: @fieldtriphealth

在推特和Instagram上關注我們:@fieldtriphealth

To receive company updates about Field Trip and to be added to the email distribution list please sign up here.

要接收有關實地考察旅行的公司更新並將其添加到電子郵件分發列表中,請在此處註冊。

Download Field Trip's app here.

點擊此處下載野外旅行的應用程序。

About the OTCQB

關於OTCQB

The OTCQB is a U.S. trading platform operated by the OTC Markets Group and is the leading marketplace of early-stage and developing U.S. and international companies. To be eligible, companies must be current in their financial reporting, undergo an annual company verification and management certification process, and meet a minimum bid price test. The OTCQB provides key benefits for investors with efficient market standards, transparency, and visibility of companies on the OTCQB market. Streamlined market standards enable Canadian companies to provide a strong baseline of transparency to inform and engage U.S. investors. To learn more, visit .

OTCQB是由OTC Markets Group運營的美國交易平臺,是初創和發展中的美國和國際公司的領先市場。要獲得資格,公司必須在其財務報告中保持最新,接受年度公司核實和管理認證過程,並滿足最低投標價格測試。OTCQB以高效的市場標準、透明度和公司在OTCQB市場上的可見性為投資者提供了關鍵好處。精簡的市場標準使加拿大公司能夠提供強大的透明度基線,以告知美國投資者並吸引他們。要了解更多信息,請訪問。

Cautionary Note Regarding Forward-Looking Information.

有關前瞻性信息的注意事項。

This release includes forward-looking information (within the meaning of Canadian securities laws) regarding the Company and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including sign-ups, downloads, engagement, reviews, ability of Field Trip to realize its business plan, grow its client base or app user base, use of the Field Trip application by users, uptake in existing or new programs by clinicians or patients, if any, acceptance of psychedelic treatments by clinicians, patients, and regulators, ability or effect of any clinical restructuring, future changes in regulatory regimes which govern Field Trip's business, and/or the ability of Field Trip to realize on its business plan for broadened, holistic approach to mental health and wellbeing. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to the Company, can be located on the SEDAR website at .

本新聞稿包括有關該公司及其業務的前瞻性信息(符合加拿大證券法的定義)。前瞻性信息往往但不總是可以通過使用諸如“預期”、“打算”、“預期”、“相信”或這些詞語和短語的變體(包括負面變體)來確定,或者聲明某些行動、事件或結果“可能”、“可能”、“將”或“將”被採取、發生或實現。這些陳述是基於公司管理層對未來事件的當前預期和看法,是基於假設的,受風險和不確定因素的影響。儘管管理層認為這些陳述所依據的假設是合理的,但它們可能被證明是不正確的。本新聞稿中討論的前瞻性事件和情況可能不會發生,可能會由於影響公司的已知和未知風險因素和不確定性而存在實質性差異,這些不確定因素包括註冊、下載、參與、審查、現場旅行實現其業務計劃的能力、擴大客户基礎或應用程序用户基礎、用户使用現場旅行應用程序、臨牀醫生或患者對現有或新計劃的接受情況、臨牀醫生、患者和監管機構對迷幻治療的接受情況、任何臨牀重組的能力或效果。未來管理field Trip業務的監管制度的變化,和/或field Trip實現其業務計劃的能力,以擴大心理健康和福祉的整體方法。儘管公司試圖確定可能導致實際行動、事件或結果與前瞻性陳述中描述的大不相同的重要因素,但可能還有其他因素導致行動、事件或結果與預期、估計或預期的不同。相應地,, 讀者不應過分依賴任何前瞻性陳述或信息。任何前瞻性陳述都不能得到保證。除適用的證券法要求外,前瞻性表述僅在作出之日發表,公司不承擔任何公開更新或修改任何前瞻性表述的義務,無論是由於新信息、未來事件或其他原因。有關公司的更多信息,可在SEDAR網站上找到。

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities.

本新聞稿不構成出售要約或徵求購買證券的要約。

Neither the TSX Venture Exchange nor its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.

多倫多證券交易所創業板交易所及其監管服務提供商均未批准本新聞稿的內容,也未對本新聞稿的充分性或準確性承擔責任。

CONTACTS:

聯繫人:

Field Trip Health & Wellness:
Ronan Levy
Chairman & CEO
(416) 505-0929
ronan@fieldtriphealth.com

實地考察健康與健康:
羅南·利維
董事長兼首席執行官
(416) 505-0929
郵箱:ronan@fieldtriphelth.com

Investor contacts:
Phil Carlson / Sophia Bashford 
KCSA Strategic Communications
(646) 573-0776 / (929) 246-7307
fieldtripIR@kcsa.com

投資者聯繫方式:
菲爾·卡爾森/索菲亞·巴什福德
KCSA戰略傳播
(646) 573-0776 / (929) 246-7307
郵箱:fieldtripIR@kcsa.com

SOURCE Field Trip Health & Wellness Ltd.

來源:野外旅行健康健康有限公司。


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論